Pathios Therapeutics
Last funding round
Raised
$25,000,000
Round
Series B
Startup details
Pathios Therapeutics is a biotech company focused on developing small molecule inhibitors of the pH-sensing G protein-coupled receptor GPR65 to counteract the GPR65 mediated immunosuppressive polarization of immune cells, including tumor associated macrophages, triggered by an acidic tumor microenvironment present in most cancers.
pathiostherapeutics.com
Oxford, United Kingdom
Established in 2017
2-10 People
Healthcare, Drug Discovery and Delivery
Founders
Investment details
Total Funding
$58,000,000
Founder Stories
Dr. Sterghois Moschos, PulmoBioMed
Recent 5 from Healthcare
Jul2024
1
3 weeks ago
London-based Beacon Therapeutics develops gene therapies for blinding retinal diseases.
Founders
David Fellows
In News
NewsnReleases
DirectorsTalk Interviews
2
3 weeks ago
Scotland-based MI:RNA Diagnostics specializes in early disease detection technology for animals using microRNA biomarkers.
Founders
Eve Hanks
In News
businessInsider
3
3 weeks ago
Colorado-based Hummingbird Healthcare streamlines patient access and operational efficiency for healthcare providers.
Founders
Jeremy Schwach
In News
Hitconsultant
4
3 weeks ago
Gurugram-based Amocare offers premium intimate wellness products with a focus on natural solutions.
Founders
Prabhat Maheshwari
In News
Entrackr
5
3 weeks ago
New York-based K Health provides AI-driven chatbot for patients before consulting physicians.
Founders
Allon Bloch
In News
Yahoo Finance
Recent 5 from United Kingdom
Jul2024
1
3 weeks ago
UK-based Natcap provides nature data for assessing risks and opportunities in corporate reporting.
Founders
Kathy Willis
In News
Carbon Pulse
2
3 weeks ago
London-based Altrove develops sustainable alternatives to critical earth materials.
Founders
Thibaud Martin,
Dr. Joonatan Laulainen
In News
Tech.eu
Tech Funding News
Yahoo Tech
StartupNews.fyi
3
3 weeks ago
UK-based TaperedPlus specializes in tech-enabled architectural design services for flat and tapered roof projects.
Founders
Robert Vass,
Aman Chahal
In News
Business Up North
4
3 weeks ago
London-based Beacon Therapeutics develops gene therapies for blinding retinal diseases.
Founders
David Fellows
In News
NewsnReleases
DirectorsTalk Interviews
5
3 weeks ago
Europe-based Trever provides infrastructure for digital asset management to financial institutions.
Founders
Hans-Jürgen Griesbacher
In News
Tech.eu